IL‐22 and IL‐22‐Binding Protein Are Associated With Development of and Mortality From Acute‐on‐Chronic Liver Failure

Interleukin‐22 (IL‐22) has context‐dependent hepatoprotective or adverse properties in vitro and in animal models. IL‐22 binding protein (IL‐22BP) is a soluble inhibitor of IL‐22 signaling. The role of IL‐22 and IL‐22BP in patients with acute‐on‐chronic liver failure (ACLF) is unclear. Beginning in...

Descripción completa

Detalles Bibliográficos
Autores principales: Schwarzkopf, Katharina, Rüschenbaum, Sabrina, Barat, Samarpita, Cai, Chengcong, Mücke, Marcus M., Fitting, Daniel, Weigert, Andreas, Brüne, Bernhard, Zeuzem, Stefan, Welsch, Christoph, Lange, Christian M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2019
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6396350/
https://www.ncbi.nlm.nih.gov/pubmed/30859151
http://dx.doi.org/10.1002/hep4.1303

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6396350/
https://www.ncbi.nlm.nih.gov/pubmed/30859151
http://dx.doi.org/10.1002/hep4.1303

Ejemplares similares